🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for female reproductive organ cancer

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice NCT06103916n/a1 site📍 Veldhoven Maxima Medical Center · Tests: Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasoun… The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy NCT07361471NA1 site📍 Clermont-Ferrand Centre Jean Perrin · Tests: molecular analysis Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites📍 Fort Myers📍 Indianapolis📍 Cleveland Frantz Viral Therapeutics, LLC · Tests: Artesunate ointment, Placebo ointment Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas NCT07215130n/a1 site📍 Kanazawa Kanazawa University · Tests: Cavitron Ultrasonic Surgical Aspirator (CUSA) Clarity ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site📍 Liverpool Pierian Biosciences · Tests: No intervention An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478Phase 11 site📍 Tianjin Suzhou BlueHorse Therapeutics Co., Ltd. · Tests: Autologous tumor infiltrating lymphocytes (TILs) Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi NCT05551208Phase 21 site📍 Chongqing Chongqing University Cancer Hospital · Tests: fluzopanib and bevacizumab Intra-lesional Tumor Boost for Bulky Cervical Cancer NCT07435376Phase 21 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: intra-lesional boost IMRT, High Dose Rate Brachytherapy A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site📍 Shanghai Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites📍 Birmingham📍 Boston📍 Boston Regeneron Pharmaceuticals · Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy NCT07144826EARLY Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Placebo Administration, Probiotic, Questionnaire Administration Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries NCT05769517n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Germinal BRCA A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682Phase 1, Phase 21 site📍 Tianjin Jacobio Pharmaceuticals Co., Ltd. · Tests: JAB-8263, JAB-8263 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites📍 Bangalore📍 Bangalore📍 Bangalore University of California, Irvine · Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer NCT06840002Phase 1, Phase 21 site📍 Wuhan Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: SHR-A1811, Carboplatin, Bevacizumab, Oxaliplatin for Injection, Paclitaxel injection IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome NCT05756023NA1 site📍 Asyut Egymedicalpedia · Tests: the pregnancy rate at IVF / ICSI cycles A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting NCT07022483Phase 386 sites📍 Fort Lauderdale📍 Miami📍 Miami Beach Daiichi Sankyo · Tests: Trastuzumab Deruxtecan, Chemotherapy Brown Adipose Tissue Modulation in Polycystic Ovary Syndrome Using Infrared Thermography NCT07896642NA2 sites📍 Istanbul📍 Istanbul Istanbul Health and Technology University · Tests: inositol A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Mind-body resilience training, Music therapy, Propranolol, Etodolac Institut Paoli Calmettes Cervical Cancer Database NCT02869490n/a1 site📍 Marseille Institut Paoli-Calmettes · Tests: Data collection A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC) NCT07108270Phase 21 site📍 Jinan GlaxoSmithKline · Tests: Dostarlimab, Carboplatin, Paclitaxel Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT). NCT07022470Phase 21 site📍 Palo Alto Stanford University · Tests: 3-Fraction HDR Brachytherapy, 4-Fraction HDR Brachytherapy a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer NCT06360653NA2 sites📍 Palermo📍 Palermo ARNAS Civico Di Cristina Benfratelli Hospital · Tests: Stereotactic Post-operative Radiotherapy for Endometrial Cancer Single cEll pRofiling PErsistaNce To ImmuNothErapy NCT06680739Phase 21 site📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: Durvalumab, Tremelimumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy